TIMELESS as a prognostic biomarker and therapeutic target in gastric cancer
TIM is identified as a promising diagnostic biomarker and therapeutic target in GC, offering valuable implications for improving patient prognosis and guiding personalized treatment strategies.
Authors
- Yan Wu (ORCID: https://orcid.org/0009-0008-3348-9232)
- Qi Sun (ORCID: https://orcid.org/0000-0001-6140-2204)
- Zhongshuang Liu (ORCID: https://orcid.org/0000-0002-8137-7349)
- Wenjing Zhang (ORCID: https://orcid.org/0000-0002-4507-5351)
- Longjiang Di (ORCID: https://orcid.org/0000-0003-4426-2216)
- Chunyang Xu (ORCID: https://orcid.org/0000-0002-2015-7094)
- Xiangrong Meng
- Shu Cao (ORCID: https://orcid.org/0000-0002-2992-8588)
Institutions
- Harbin Medical University (CN)
- Shenzhen University (CN)
- First Affiliated Hospital of Heilongjiang University of Chinese Medicine (CN)
- Second Affiliated Hospital of Harbin Medical University (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Journal of Genetic Engineering and Biotechnology
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1016/j.jgeb.2025.100504
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Health and Family Planning Commission of Heilongjiang Province